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An unusual Salmonella species, S. choleraesuis subsp. indica serovar bornheim, was isolated from the urine
of a patient with aplastic anemia, diabetes mellitus, and a healed urethral injury. An immune response to this
isolate was demonstrated by whole-bacterial-cell agglutination.
Although infections due to salmonellae are common
worldwide, serovars other than those belonging to subspe-
cies I are rarely pathogenic to humans (3, 5). In addition,
salmonellae are rarely reported as etiological agents of
urinary tract infection (UTI) (1). We report a case of UTI
caused by serovar bornheim (S. bomheim), a member of
Salmonella choleraesuis subsp. indica (VI).
A 32-year-old man with aplastic anemia with leukopenia,
diabetes mellitus, and a healed urethral injury after pelvic
trauma in an accident 7 years earlier was admitted to the
hematology unit. He was given anti-T-cell monoclonal anti-
bodies for 5 days from day 7 of admission, in addition to
prednisolone (10 mg twice a day). Twenty-two days after
admission, he developed fever and increased frequency of
and a burning sensation on micturition. Upon microscopic
examination of his urine, approximately 20 polymorphonu-
clear leukocytes and 30 erythrocytes per high-power field
were seen. A midstream clean-catch specimen of urine was
transported without delay to the laboratory for culture; 0.01
ml was plated on blood agar for isolation and on MacConkey
agar for colony counting (8). After overnight incubation at
37°C, a pure growth of nonhemolytic and non-lactose-fer-
menting colonies grew to a colony count of > 105/ml. This
isolate was identified as Salmonella species, based on bio-
chemical reactions and agglutination with Salmonella poly-
valent 0 antiserum (A-I and Vi) (Difco Laboratories, De-
troit, Mich.). The screening biochemical tests used included
an acid butt with gas and H2S on triple sugar iron agar
medium, mannitol fermentation, citrate utilization, lysine
decarboxylation, and negative tests for indole and urease (3)
(Table 1). Antimicrobial susceptibility tests were done by the
modified Kirby-Bauer disk diffusion method (10). Staphylo-
coccus aureus and Escherichia coli with known zone sizes
for each antibiotic were used as controls. The Salmonella
isolate was sensitive to chloramphenicol (30 ,ug per disk),
ampicillin (10 ,ug), co-trimoxazole (1.25/23.75 ,ug), tetracy-
cline (30 ,ug), gentamicin (10 p,g), cephalothin (30 p,g),
norfloxacin (10 ,g), and nalidixic acid (30 ,ug). Zone size was
interpreted according to the National Committee on Clinical
Laboratory Standards chart (vol. 7, 1988).
A blood culture done immediately after the isolation of
Salmonella species from the urine was sterile. The patient's
serum sample was tested for the presence and titer of
agglutinating antibodies against the isolate. The isolate was
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grown on nutrient agar, harvested, suspended in 0.85%
saline, and treated with absolute alcohol to a final concen-
tration of 33%. The opacity was adjusted to that of Browne's
tube no. 3 (2). The serum was diluted in serial twofold steps
in 0.85% saline. To 0.5 ml each of the serum dilutions, an
equal volume of the antigen cell suspension was added, and
the tubes were incubated at 37°C for 18 h. Agglutination was
seen up to a dilution of 1:640.
The patient was given 400 mg of norfloxacin twice daily for
5 days, and he became symptom-free. A second urine
culture 4 days after treatment was started did not yield any
growth. The Salmonella isolate was sent to the National
Salmonella and Escherichia Centre at the Central Research
Institute, Kasauli, India. It was identified as belonging to
subspecies VI (indica) by the criteria shown in Table 1. The
isolate was found to have an antigenic profile of S.VI
1,6,14,25:Z10:1(2),7. Hence it was identified as Salmonella
bornheim.
The patient was diagnosed as having UTI because of the
symptoms and pyuria. A midstream clean-catch specimen of
urine yielded > 105 CFU of S. bomheim per ml in pure
culture. Hence, this organism was considered to be the
causative agent and not part of the fecal flora contaminating
the urine.
Salmonellae are rare causes of UTI. In males, such
infections are associated with urinary tract abnormalities
(11). The patient reported here had an earlier injury of the
urinary tract; we believe that this was a risk factor for his
unusual infection. Aplastic anemia, the associated leukope-
nia, and the immunosuppressive treatment also could have
contributed. Finding Salmonella species in the urine need
not necessarily mean UTI caused by Salmonella species,
since bacteruria may follow bacteremia. One blood culture
done in this patient was sterile. This culture, however, was
done after the isolation of S. bornheim from the urine. In
bacteremic Salmonella infections like enteric fever, the
blood culture is usually positive during week 1 of illness,
while the urine culture becomes positive only around week
3. This patient had a fever for 4 days, 1 week before the
onset of UTI. No cultures were done at this stage, and
therefore a preceding bacteremia cannot be ruled out.
According to the currently accepted taxonomic classifica-
tion, there are two species of Salmonella, S. choleraesuis
and S. bongori (9). Most salmonellae causing human infec-
tions belong to S. choleraesius. Many workers prefer the
term S. enterica for this species (3, 9). This species has six
subspecies, S. enterica subsp. enterica, subsp. salamae,
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TABLE 1. Results of tests done for identification of S. choleraesuis serovar bornheima
Test Result Test Result
Motility ......................................... +
Methyl red .+
Glucose..........................................AGb Voges-Proskauer.
Lactose .......................................... - Urease.
Sucrose ......................................... - Gelatinase.+
Maltose ......................................... AG Mucate.+
Mannitol.......................................... AG H2S.+
Dulcitol .......................................... - Indole.
Salicin ........................... - Phenyl alanine deaminase.
Adonitol ........................................... - KCN.
Inositol ........................... - Lysine decarboxylase .+
Sorbitol ........................................... - Arginine dihydrolase.+
Cellobiose.......................................... - Ornithinedecarboxylase.+
Xylose ......................................... AG
Mannose......................................... AG Simmonscitrate.+
Arabinose ......................................... AG O-Nitrophenyl-3-D-galactopyranoside.
Trehalose......................................... AG Malonate.
Rhamnose......................................... AG D-tartrate.
Raffinose .......................................... - meso-tartrate.
Melibiose......................................... AG .L-tartrate.
Galacturonate.+
a Characteristic reactions for subspecies VI are underlined.
b AG, acid and gas.
subsp. arizonae, subsp. diarizonae, subsp. houtenae, and
subsp. indica. Subspecies VI (indica) was described by
LeMinor et al. (7) in 1986, based on biochemical and
genomic characteristics. Biochemically, this subspecies can
be identified by five properties. They produce gelatinase, do
not utilize malonate and L-tartrate, and do not ferment
salicin and sorbitol (7). Ten serovars are assigned to this
subspecies (9). The initial isolation of S. bomnheim was from
Cordylus cordylus in the Frankfurt Zoo in 1964 (4). S.
bomnheim was then placed in subgenus II of Kauffmann and
shifted to subspecies VI in 1988 (6). A literature search done
for the word "bornheim" on MEDLINE for the years 1966
to 1991 did not detect any report of human infection caused
by S. bornheim.
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